Ausgabe 3/2021
Pancreatic Cancer Microenvironment: Modern Understanding and Newer Treatments
Inhalt (23 Artikel)
Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration
Nicolas G. Bazan, Madigan M. Reid, Valerie A. Cruz Flores, Juan E. Gallo, William Lewis, Ludmila Belayev
Pancreatic cancer pathology viewed in the light of evolution
Michaël Noë, Seung-Mo Hong, Laura D. Wood, Elizabeth D. Thompson, Nicholas J. Roberts, Michael G. Goggins, Alison P. Klein, James R. Eshleman, Scott E. Kern, Ralph H. Hruban
The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
Cameron J. Herting, Isaac Karpovsky, Gregory B. Lesinski
The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
Kalyani Patil, Farheen B. Khan, Sabah Akhtar, Aamir Ahmad, Shahab Uddin
Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics
Sophia G. Kisling, Gopalakrishnan Natarajan, Ramesh Pothuraju, Ashu Shah, Surinder K. Batra, Sukhwinder Kaur
Impact of posttranslational modifications in pancreatic carcinogenesis and treatments
Nianhong Chen, Qiaoqiao Zheng, Guoqing Wan, Feng Guo, Xiaobin Zeng, Ping Shi
Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer
Lorenzo F. Sempere, Katherine Powell, Jatin Rana, Andrew A. Brock, Thomas D. Schmittgen
The role of microbiome in pancreatic cancer
Jenny Jing Li, Mojun Zhu, Purna C. Kashyap, Nicholas Chia, Nguyen H. Tran, Robert R. McWilliams, Tanios S. Bekaii-Saab, Wen Wee Ma
Models of pancreatic ductal adenocarcinoma
Rayane Dennaoui, Hridaya Shrestha, Kay-Uwe Wagner
Targeting KRAS in pancreatic cancer: new drugs on the horizon
Sahar F. Bannoura, Md. Hafiz Uddin, Misako Nagasaka, Farzeen Fazili, Mohammed Najeeb Al-Hallak, Philip A. Philip, Bassel El-Rayes, Asfar S. Azmi
Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance
Thatcher Heumann, Nilofer Azad
Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance
Thatcher Heumann, Nilofer Azad
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Guido Eibl, Enrique Rozengurt
Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology
William A. Hall, Mandana Kamgar, Beth A. Erickson, Sara Beltrán Ponce, Susan Tsai, Marja T. Nevalainen, Kathleen K. Christians, Ben George, Kulwinder S. Dua, Abdul H. Khan, Douglas B. Evans, Asfar S. Azmi
Targeting DNA damage repair pathways in pancreas cancer
Fionnuala Crowley, Wungki Park, Eileen M. O’Reilly
Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020
Simona Giunta
The comprehensive landscape of miR-34a in cancer research
Sijing Li, Xiaohui Wei, Jinyong He, Quanquan Cao, Danyu Du, Xiaoman Zhan, Yuqi Zeng, Shengtao Yuan, Li Sun
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
Marek Z. Wojtukiewicz, Magdalena M. Rek, Kamil Karpowicz, Maria Górska, Barbara Polityńska, Anna M. Wojtukiewicz, Marcin Moniuszko, Piotr Radziwon, Stephanie C. Tucker, Kenneth V. Honn